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Background: Severe Acute Respiratory Infection (SARI) is responsible for mortality and hospital admissions 
in millions of people across the world. The present study, for the first time, aimed at estimating the incidence, 
mortality, and burden of SARI in Iran in 2015. 
Methods: Disability Adjusted Life Years (DALYs) was used as an index to estimate the burden of SARI. The 
SARI-related DALYs was calculated using a method developed by the WHO for assessing the Global Burden 
of Diseases. DALYs are calculated as the sum of the Years Lost due to Disability (YLDs) and the Years of Life 
Lost (YLLs) due to premature mortality. The data on the incidence and mortality were obtained from the SA-
RI surveillance system of Iran's Ministry of Health and Medical Education. The average duration until remis-
sion or death and the disease disability weight were set at four weeks and 0.373, respectively.  
Results: In 2015, the incidence of SARI was 21309 and 20885 among males and females, respectively. Moreo-
ver, 773 males and 737 females died from this disease (Case fatality rate was about 0.035). Total SARI-related 
DALYs in males and females was 17264 and 16720, respectively. Furthermore, YLLs was responsible for more 
than 96% of SARI-related DALYs in 2015. 
Conclusion: There was no significant difference between males and females in terms of the incidence, mortal-
ity, and burden of SARI in 2015. Epidemiological data are required to adopt appropriate policies and responses 
to prevent and control SARI. The incidence, mortality, fatality, and burden of SARI are significant in Iran. It is 
necessary to develop appropriate strategies, such as vaccination against major pathogens of the disease at least 
in high-risk groups, strengthening the disease surveillance system, and attracting the attention of policy makers 
and health authorities of the country. 
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Introduction 
 
Severe Acute Respiratory Infection (SARI) is re-
sponsible for millions of deaths and hospital ad-
missions across the world annually (1). Around 
4.2 million cases of death from SARI occur an-
nually in the world (2). It imposes a high socio-
economic burden on communities and is one of 
the leading causes of hospital admissions in chil-
dren. In 2010, about 11 million children under 
the age of 5 affected by SARI were hospitalized 
in developing countries, and the disease fatality 
rate was estimated to be 2.3% (3).SARI is caused 
by a wide range of microbial agents followed by 
cough and history or presence of a fever (≥38 °C, 
sublingual). The patients with this disease must 
be hospitalized (4-6). 
As estimated in 2010, severe and very severe 
Acute Lower Respiratory Infections (ALRI), re-
spectively, were responsible for 11.9 and 3 mil-
lion hospital admissions among children under 5 
year of age worldwide. It also caused 265000 in-
hospital deaths in young children, with 99% of 
the deaths occurring in developing countries. Of 
all children affected by severe ALRI worldwide, 
62% were treated in hospitals; however, 81% of 
deaths from the disses occurred in patients not 
admitted to hospitals (3). SARI is responsible for 
many outbreaks and hospital admissions in Iran 
(7, 8). The rates of the disease incidence and 
mortality are recorded by SARI surveillance sys-
tem in Iran.  
In order to prevent and control SARI, proper 
and reliable epidemiological data are needed for 
making policies and adopting appropriate re-
sponse against SARI. Burden of disease is one of 
the important epidemiological information. Disa-
bility-Adjusted Life Years (DALYs) is an index 
developed by the WHO, the World Bank, and 
the Health School of Harvard University for as-
sessing the burden of diseases (9-11). 
Estimating the burden of diseases helps health 
sector authorities to better allocate health re-
sources, set goals, focus on high-risk areas, and 
evaluate health care interventions. To the best of 
our knowledge, this study is the first that aimed 
at estimating the incidence and burden of SARI 




Disability-Adjusted Life Years (DALYs) and the 
National Burden of Disease indices developed by 
the WHO were used for calculating the burden 
of SARI (11). DALYs is calculated through add-
ing Years of Life Lost due to premature death 
(YLLs) to Years of Life Lost due to disability 
(YLDs) (12, 13). 
DALY= YLL+ YLD 
YLL is the number of deaths (N) multiplied by 
Iranian life expectancy at the age of death in 
years 
YLL=N × L 
The data on the incidence and mortality from the 
disease was obtained from the SARI surveillance 
system of Iran's Ministry of Health in 2015. In 
this study, SARI was defined as a disease caused 
by a wide range of microbial agents followed by 
cough and history or presence of a fever (≥38 °C, 
sublingual) (4, 14). As pointed out by the health 
sector experts, SARI surveillance system is one of 
the best surveillance systems in Iran that covers 
about 80% of cases with SARI. Therefore, a co-
efficient of 1.25 was applied for estimating the 
real incidence of this disease. No age weight was 
applied in calculations; however, a discount rate 
of 0.03 was applied for discounting health values 
in future years. 
For each age group, the mean age of that group 
was considered as the mortality age for patients 
died from SARI. However, the average age of 
mortality for 0-1 and 1-5 age groups was set at 
0.1 and 2.6, respectively. Life expectancy left for 
each age group was calculated using life tables of 
Iranians reported by the WHO.  
YLDs was calculated through multiplying the in-
cident rate (I) by the average duration of the dis-
ease until remission or death (D) multiplied by 
disability weight (DW). 
YLD= I ×DW × D 
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After holding an expert panel, the average period 
of the disease and its disability weight were set at 
four weeks (0. 0767 years) and 0.373, respectively 
(12). The disability weight varied from 0 (com-
plete health) to 1 (death) (11).The data on the 
population of the country and its provinces in the 
year of the study were obtained from statistical 
center of Iran(15).The collected data were ana-




Table 1 presents the incidence, mortality, and 
burden of SARI in Iran in 2015. Total DALYs 
among males and females was 17264 and 16720, 
respectively. The highest and the lowest 
DALYs/100000 population in both sexes were 
observed among 0-4 and 5-14 age groups, respec-
tively.




Sex Total cases 
of SARI 










0-4 Male 3130 91.42 94 89.44 2820.08 84.98 
Female 3068 93.70 90 87.67 2707.02 85.35 
5-14 Male 1681 28.55 51 48.04 1493.51 25.21 
Female 1648 27.99 49 47.09 1435.91 25.19 
15-29 Male 3494 34.30 126 99.84 3398.59 33.58 
Female 3425 33.63 121 97.87 3281.44 33.18 
30-44 Male 4467 42.63 189 127.65 4567.59 44.81 
Female 4376 39.73 181 125.05 4421.67 41.28 
45-59 Male 3570 59.77 148 102.01 2786.03 48.35 
Female 3499 62.57 142 99.99 2714.49 50.33 
60-69 Male 2152 104.51 67 61.49 917.28 47.53 
Female 2109 98.70 64 60.28 896.77 44.79 
70-79 Male 1583 167.28 61 45.24 519.95 59.73 
Female 1552 185.84 58 44.35 514.60 66.93 
+80 Male 1233 342.64 35 35.23 152.37 52.13 
Female 1208 335.70 33 34.53 151.00 51.56 
Total Male 21309 53.58 773 608.94 16655.40 43.41 
Female 20885 53.16 737 596.81 16122.90 42.56 
 
Figure 1 presents the percentage of YLLs and 
YLDs from the total burden of SARI by sex in 
2015. YLLs was responsible for more than 96% 




Fig. 1: Share of YLL and YLD in the total burden of SARI (DALY) in 2015 
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Figure 2 illustrates the burden of SARI by sex 
and age in 2015. Of all age groups, 30-44 age 
group had the highest crude DALYs in both 
males and females. The burden of SARI among 




SARI is responsible for mortality and hospital 
admissions in millions of people across the 
world. To prevent and control SARI, epidemio-
logical data are required for making appropriate 
policies and adopting proper responses against 
the disease. Our study aimed at providing the 
data on the incidence, mortality, and burden of 
SARI in Iran. 
In 2015, the total incidence of SARI among 
males and females, respectively, were 21309 and 
20885 cases across the country (incidence rate 




Fig. 2: Share of each sex in the burden of SARI (DALYs) by age-group in 2015 
 
Between 2012 and 2014, 8929 cases with SARI 
were hospitalized in Kenya. The incidence of the 
disease was estimated to be 21 per 100,000 peo-
ple. However, the method used for calculating 
the incidence of SARI in the mentioned study 
was different from the method used in our study 
(16). 
Reducing the rate of SARI is still one of the main 
priorities and challenges in African and develop-
ing countries (13, 17). Our results indicated that 
the incidence of SARI in children and the elderly 
is higher. The incidence of the disease among 
children was higher than the rates reported 
among the same age group in European and 
American countries (18). Children under the age 
of five and the elderly are among the high-risk 
groups at risk of severe influenza (3). In South 
Africa and Kenya, the incidence of SARI in chil-
dren under the age of 5 is 56-276 per 100,000 and 
92-110 per 100,000 people, respectively (16, 19). 
About 11,570,000 children under the age of 5 
with SARI are annually admitted to hospitals in 
developing and developed countries (3). 
In Kenya, the incidence of SARI was 12.4/100 
population among children under the age of 5 
years. In order to treat and prevent SARI it is 
necessary to pay attention to influenza virus 
pathogens and respiratory syncytial virus (RVS) 
and develop related technologies and strategies 
(20).  
Respiratory syncytial virus- acute lower respirato-
ry infection (RSV-ALRI) caused 3.2 million (2.7-
3.8) hospital admissions among children under 5 
year of age across the world in 2015. The esti-
mated value might be attributed to some factors 
such as health services-seeking behavior among 
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people, location, geographical status of the stud-
ied area, and the use of diagnostic methods (21). 
In line with the results of our study, the rate of 
hospital admission among males was higher than 
that among females. The observed difference 
might be attributed to the size of breathing chan-
nel in males which is smaller than that in females, 
the higher level of attention paid to boys, and the 
higher demand for health services for males (21-
23). In Madagascar, 54.8% of cases with SARI 
were male (24). 
Based on our findings, SARI killed 773 males and 
737 females in Iran in 2015; the disease fatality 
rate was about 0.035. Annually, around 4.2 mil-
lion deaths from SARI occur in the world; the 
disease fatality rate in developing and developed 
countries is estimated to be 2.3% and 0.6%, re-
spectively (3). Moreover, in 2015, RSV-ALRI in-
fections were responsible for 59600 deaths 
(48000-74500) among children under 5 year of 
age across the world, and 99% of the deaths were 
observed in developing countries (21). Access to 
hospital care was one of the main determinants 
of SARI death in developing countries (25, 26).  
In our study, total SARI-related DALYs among 
males and females were 17264.3 and 16719.7, 
respectively in 2015. Children (0-4 age group) and 
the elderly had the highest DALYs (per 100000 
population). In addition, YLL was responsible for 
96% of DALYs in both sexes, indicating the high 
fatality rate of SARI. Based on the Global Bur-
den of Disease (GBD) reports, lower and upper 
respiratory infections caused 103.05 million 
DALYs (1428.8 DALYs/100000 population) and 
2.87 million DALYs (38.7 DALYs/100000 popu-
lation), respectively in 2015. In line with the re-
sults of our study, the highest incidence of the 





The incidence, mortality, and burden of SARI are 
significant in Iran, indicating the need to pay 
more attention to this disease. The incidence, 
mortality, and burden of SARI were 42194 cases, 
1510 deaths, and 33984 DALYs, respectively, and 
there was no significant difference between males 
and females in terms of the mentioned items. In 
order to prevent and control this disease, epide-
miological evidence are required for making poli-
cies and adopting a proper response against SA-
RI; the results of our study can provide such 
evidence for making policies. In order to control 
the disease, it is necessary to strengthen SARI 
surveillance system, implement vaccination pro-
grams against major pathogens of the disease at 
least in high-risk groups, and attract the attention 
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